Premium
Prognostic value of apoptosis and apoptosis‐associated proteins in salivary gland adenoid cystic carcinoma
Author(s) -
Jia Lin,
Esguerra Renelson L.,
Tang Xiaofei,
Yin Hongfang,
Sakamoto Kei,
Okada Norihiko,
Takagi Minoru
Publication year - 2004
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/j.1440-1827.2004.01611.x
Subject(s) - tunel assay , apoptosis , adenoid cystic carcinoma , immunohistochemistry , salivary gland , pathology , terminal deoxynucleotidyl transferase , biology , carcinoma , mdm2 , p53 protein , cancer research , medicine , biochemistry
The purpose of the present study was to investigate the level of apoptosis and expressions of p53, mdm2 and bcl‐2 proteins in salivary gland adenoid cystic carcinoma (ACC) to determine potential relationships among apoptosis, apoptosis‐associated proteins and clinical cumulative survival. Thirty‐nine formalin‐fixed, paraffin‐embedded cases, cribriform (17), tubular (13) and solid (9), were studied by immunohistochemistry. Apoptosis detection and analysis were determined by terminal deoxynucleotidyl transferase‐mediated dUTP‐biotin nick‐end labeling (TUNEL). There was an inverse significance between the apoptotic index (AI) and bcl‐2 expression ( P = 0.018), whereas no correlation was found between the AI and either p53 or mdm2 expression ( P = 0.416 and P = 0.456). Co‐expression of p53 and mdm2 was found in 22 cases ( P = 0.037). Patients with p53‐positive tumors had a worse prognosis than those with p53‐negative tumors ( P = 0.014). Patients with a high AI had a better cumulative survival than patients with a low AI ( P = 0.038). The present study suggests that p53 expression and AI can be useful as prognostic values; bcl‐2 protein plays a role in the down‐regulation of apoptosis and is also potentially useful as a prognostic parameter in salivary gland ACC.